New Nature study reveals mRNA COVID vaccines (Pfizer/Moderna) may double 3-year survival in advanced melanoma/lung cancer patients on immunotherapy.
New Nature study reveals mRNA COVID vaccines (Pfizer/Moderna) may double 3-year survival in advanced melanoma/lung cancer patients on immunotherapy.